Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms

Abroad (travel likely)Recruiting

Conditions

Psoriatic Arthritis · Depression · Psoriatic Plaque

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Queen Elizabeth University Hospital, Glasgow, Scotland, United Kingdom
Contact: Study coordinator (Maxine Arnott) · maxine.arnott@glasgow.ac.uk · 07890059695
Neil Basu, MD, PhD (Sub-investigator)
Contact: Principal Investigator (Jonathan Cavanagh, MD)

Study leads

Jonathan Cavanagh, MD, PhD
Principal Investigator
University of Glasgow

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Moderate to Severe Plaque Psoriasis · Psoriatic Arthritis · Axial Spondyloarthritis

Abroad (travel likely)RecruitingPHASE1

Santa Monica, United States · South Miami, United States

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Psoriatic Arthritis · Axial Spondyloarthritis

Abroad (travel likely)RecruitingPHASE1

Peoria, United States · Apple Valley, United States

A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis

PsA (Psoriatic Arthritis)

Abroad (travel likely)RecruitingPHASE2

Chengdu, China

A Study of Picankibart in Patients With Active Psoriatic Arthritis

Psoriatic Arthritis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Hangzhou, China